Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FAIR-PARK II: Conservative iron chelation in Parkinson's disease
2015-003679-31Phase 2Completed
- Sponsor
- CHU de Lille
- Start
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in Parkinson's disease (PD) comparing Deferiprone with Placebo (2 arms). Started Jan 2016; status: completed.
02
Drugs
deferiprone
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on 2015-003679-31.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-003679-31.